Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioCardia, Inc. Director's Dealing 2020

Jul 1, 2020

35081_dirs_2020-07-01_a4266218-b639-4732-a848-8074f63fc1f4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioCardia, Inc. (BCDA;BCDAW)
CIK: 0000925741
Period of Report: 2020-06-30

Reporting Person: STERTZER SIMON H (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-06-30 Common Stock A 4531 Acquired 192514 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 709513 Indirect
Common Stock 230704 Indirect
Common Stock 11656 Indirect
Common Stock 91544 Indirect

Footnotes

F1: The award relates to vested restricted stock units ("RSUs") granted June 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (i) two years from the date of grant, (ii) the date the director ceases to be a service provider, or (iii) such other date as the administrator determines under the Issuer's 2016 Equity Incentive Plan.

F2: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees.

F3: These shares are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are the sole members and managers.

F4: These shares are held by the Stertzer Gamma Trust, of which the Reporting Person is the grantor.

F5: These shares are held by Stertzer Holdings LLC, and the Reporting Person may be deemed to have beneficial ownership of such shares.